Science
Drew Moghanaki
Drew Moghanaki/LinkedIn

Drew Moghanaki: Shift in Radiation Therapy Intent for NSCLC Over the Past Decade

Drew Moghanaki, Chief Medical Officer at Respirati, shared a post on X:

“A Norwegian study reveals a significant shift in the intent of radiation therapy treatments for NSCLC over the past decade, with a higher proportion prescribed for cure and less for palliation.”

Drew Moghanaki: Shift in Radiation Therapy Intent for NSCLC Over the Past Decade

Title: Changes in use of radiotherapy for lung cancer – A Norwegian population-based study from 2000 until 2020

Authors: Gustav Graabak, Tarje Onsøien Halvorsen, Bjørn Henning Grønberg, Kristin Toftaker Killingberg

Read The Full Article at Lung Cancer.

Drew Moghanaki: Shift in Radiation Therapy Intent for NSCLC Over the Past Decade

More posts featuring Drew Moghanaki on OncoDaily.

Bjørn Henning Grønberg cancer Drew Moghanaki Gustav Graabak Kristin Toftaker Killingberg OncoDaily Oncology Tarje Onsøien Halvorsen